Skip to content
10-Q

Quarterly Report

EnzymeBioSystems

0001493152-18-006376

← back to feed
Filed
May 8, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · May 4, 2018 5.59M sh
Operating Cash Flow Q3 2018 · Mar 31, 2018 −$205.78K
Operating Cash Flow Q3 2018 · Mar 31, 2017 −$74.3K
Cash And Equivalents Q3 2018 · Mar 31, 2018 $391.42K
Cash And Equivalents Q3 2018 · Jun 30, 2017 $41.25K
Cash And Equivalents Q3 2018 · Mar 31, 2017 $65.74K
Cash And Equivalents Q3 2018 · Jun 30, 2016 $140.04K
Stockholders Equity Q3 2018 · Mar 31, 2018 $388.82K
Stockholders Equity Q3 2018 · Jun 30, 2017 $40.15K
Current Liabilities Q3 2018 · Mar 31, 2018 $2.6K
Current Liabilities Q3 2018 · Jun 30, 2017 $4.1K
Total Liabilities Q3 2018 · Mar 31, 2018 $2.6K
Total Liabilities Q3 2018 · Jun 30, 2017 $4.1K
Current Assets Q3 2018 · Mar 31, 2018 $391.42K
Current Assets Q3 2018 · Jun 30, 2017 $44.25K
Total Assets Q3 2018 · Mar 31, 2018 $391.42K
Total Assets Q3 2018 · Jun 30, 2017 $44.25K
Net Income Q3 2018 · Mar 31, 2018 −$33.73K
Net Income Q3 2018 · Mar 31, 2018 −$605.28K
Net Income Q3 2018 · Mar 31, 2017 −$17.72K
Net Income Q3 2018 · Mar 31, 2017 −$74.3K
Operating Income Q3 2018 · Mar 31, 2018 −$33.88K
Operating Income Q3 2018 · Mar 31, 2018 −$606.22K
Operating Income Q3 2018 · Mar 31, 2017 −$32.72K
Operating Income Q3 2018 · Mar 31, 2017 −$89.3K